EUVIMEDEUVIMED entdecken
Crossref

Impact of chronic anticoagulation on perioperative outcomes in patients undergoing minimally invasive bariatric surgery—Propensity score–matched analysis using the 2020–2021 Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program

Elad Boaz, Pauline Aeschbacher, Noam Kahana, Nir Horesh, Emanuele Lo Menzo, Samuel Szomstein, Raul J Rosenthal

Surgery for Obesity and Related Diseases · 2026

DOI: 10.1016/j.soard.2025.09.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Surgery for Obesity and Related Diseases, 2026. Verfasst von Elad Boaz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Cleveland Clinic Florida, Weston, Florida; Department of General surgery, Shaare Zedek Medical Center, Faculty of Medi…. Hauptthemen laut MEDLINE: Bariatric Surgery, Anticoagulants, Minimally Invasive Surgical Procedures. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The management of individuals receiving chronic anticoagulation (CAC) who are undergoing bariatric surgery presents a complex challenge, because there is a delicate balance between risks of perioperative bleeding and thromboembolic events. OBJECTIVES: To evaluate and compare rates of bleeding, thrombotic events, and overall outcomes of patients on CAC undergoing bariatric surgery. SETTING: United States. METHODS: Data spanning 2020 to 2021 were extracted from the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program database, with a focus on patients who underwent primary minimally invasive bariatric surgery. A multivariable regression analysis examined 30-day outcomes for patients anticoagulated preoperatively. In addition, a propensity-matched analysis was performed comparing outcomes among patients on CAC and those without. RESULTS: In total 331,201 patients were analyzed, with 8428 (2.5%) receiving CAC. Propensity score matching revealed that patients on CAC exhibited greater rates of reoperations within 30 days (1.9% versus 1.3%, P < .001), overall readmissions after 30 days (7.2% versus 3.3% respectively, P < .0001), and reinterventions within 30 days (1.6% versus .9%, P < .0001) compared with patients not on preoperative CAC. Transfusion intra/postoperative and postoperative gastrointestinal tract bleeding events were elevated in the preoperative therapeutic anticoagulant group (2.2% versus .8%, P < .0001 and 1.4% versus .3%, P < .0001, respectively) compared with no preoperative CAC group. CONCLUSIONS: Patients undergoing bariatric surgery while on preoperative CAC face significantly increased risks of adverse postoperative outcomes. Individuals requiring long-term anticoagulation should undergo careful consideration before proceeding with bariatric surgery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bariatric SurgeryAnticoagulantsMinimally Invasive Surgical ProceduresHumansPropensity ScoreFemaleMaleMiddle AgedQuality ImprovementAdultObesity, MorbidThromboembolismPostoperative ComplicationsUnited StatesRetrospective StudiesTreatment OutcomeReoperationPostoperative Hemorrhage

Stichwörter der Autor:innen

Bariatric surgeryBleedingChronic anticoagulationObesityThromboembolic risk

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Department of General Surgery, Cleveland Clinic Florida, Weston, Florida; Department of General surgery, Shaare Zedek Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Department of General Surgery, Cleveland Clinic Florida, Weston, Florida.
  • Department of General Surgery, Cleveland Clinic Florida, Weston, Florida; Department of Surgery and Transplantations, Sheba Medical Center, Ramat Gan, Israel, Tel Aviv University, Tel Aviv, Israel.
  • Department of General Surgery, Cleveland Clinic Florida, Weston, Florida. Electronic address: rosentr@ccf.org.

Zitieren

APA

Boaz, E., Aeschbacher, P., Kahana, N., Horesh, N., Lo Menzo, E., Szomstein, S., & Rosenthal, R. J. (2026). Impact of chronic anticoagulation on perioperative outcomes in patients undergoing minimally invasive bariatric surgery—Propensity score–matched analysis using the 2020–2021 Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program. Surgery for Obesity and Related Diseases. https://doi.org/10.1016/j.soard.2025.09.004

Vancouver

Boaz E, Aeschbacher P, Kahana N, Horesh N, Lo Menzo E, Szomstein S, et al. Impact of chronic anticoagulation on perioperative outcomes in patients undergoing minimally invasive bariatric surgery—Propensity score–matched analysis using the 2020–2021 Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program. Surgery for Obesity and Related Diseases. 2026. doi:10.1016/j.soard.2025.09.004

BibTeX
@article{Boaz2026,
  author = {Boaz, Elad and Aeschbacher, Pauline and Kahana, Noam and Horesh, Nir and Lo Menzo, Emanuele and Szomstein, Samuel and Rosenthal, Raul J},
  title = {Impact of chronic anticoagulation on perioperative outcomes in patients undergoing minimally invasive bariatric surgery—Propensity score–matched analysis using the 2020–2021 Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program},
  journal = {Surgery for Obesity and Related Diseases},
  year = {2026},
  doi = {10.1016/j.soard.2025.09.004}
}
Kostenlos starten →